HB 7438

House·20th Congress·Filed Jan 27, 2026

An Act Streamlining Access to Investigational Drugs, Biologics, and Medical Devices for Patients with Life-Threatening or Seriously Debilitating Conditions, Establishing the Expanded Access and Right to Try Framework, and for Other Purposes

In plain language

The proposal would create a streamlined system that lets patients with serious or life‑threatening illnesses obtain unapproved drugs, biologics, or devices when standard treatments have failed, by setting faster FDA review times, an emergency‑use shortcut, and liability protections for doctors and manufacturers.

HealthConsumer Protection

Automated summary by BatasWatch. It may miss nuance — read the bill text before citing it.

Author · Representative

Adrian E. SalcedaReceipts →

Official sources

Similar in what they’d do, filed by any lawmaker.

HB 6317· Filed Nov 24, 2025
An Act Authorizing the Director General of the Food and Drug Administration to Issue Emergency Use Authorization, Further Amending Republic Act No. 3720, Otherwise Known as the "Food, Drug, and Cosmetic Act," as Amended by Republic Act No. 9711, O?herwise Known as the "Food and Drug Administration (Fda) Act of 2009"
Pending with the Committee on HEALTH since 2025-11-26Rep. Keith Micah "Atty. Mike" D.l. Tan
HB 10922· Filed Aug 24, 2026
An Act Modernizing the Food and Drug Administration by Imposing Enforceable Processing Timelines with Automatic Approval for Low-Risk Applications, Giving Permanent Statutory Footing to the Regulatory Reliance Pathways, Eliminating the Application Backlog and Preventing Its Recurrence, Mandating Full Digitalization, Strengthening Testing and Human Resource Capacity, Amending for the Purpose Pertinent Provisions of Republic Act No. 9711, and Appropriating Funds Therefor
Pending with the Committee on HEALTH since 2026-08-26Rep. Elmer V. Catulpos
HB 9221· Filed May 12, 2026
An Act to Accelerate the Discovery and Development of Innovative Medicines by Strengthening Clinical Trials, and for Other Purposes
Pending with the Committee on HEALTH since 2026-05-18Rep. Florabel C. Yatco
HB 8755· Filed Mar 24, 2026
An Act Strengthening the Regulation of Online Transactions Involving Health Products, Expanding the Powers of the Food and Drug Administration Under Republic Act No. 9711, and Enhancing Republic Act No. 11967 (Internet Transactions Act), Imposing Liability on Digital Platforms, and for Other Purposes
Pending with the Committee on TRADE AND INDUSTRY since 2026-05-13Rep. Eric L. Olivarez
HB 4259· Filed Sep 1, 2025
An Act to Accelerate the Discovery and Development of Innovative Medicines by Strengthening Clinical Trials, and for Other Purposes
Pending with the Committee on HEALTH since 2025-09-03Rep. Ferdinand Martin G. Romualdez +3

Spot something wrong?

HB07438 · Sources: BatasWatch